Contract Operations

So Much More Than Just Processing Claims

Government Pricing

At PharmaMetrics, we manage and administer all types of Managed Markets Contracts.  We work seamlessly with an experienced partner to provide the following services:

  • Calculation and reporting of monthly and quarterly government pricing requirements to support Medicaid, Federal Supply Schedule, Tricare and PHS Covered Entity (340B) Agreements.
  • Product launch guidance
  • Insight into on how Government Prices are calculated, Class of Trade (COT) set-up and validation
  • Dispute Avoidance
  • FSS solicitation preparation, negotiation coaching and contract administration
  • TRICARE Medicaid, and Public Health Service Covered Entity Agreement preparation.
  • Standard Operating Procedures
  • Government Program Training (Onsite or web based)
  • Audit readiness

More information:

For more information regarding this service, please contact us at 215-274-1316.

  •  “What sets PharmaMetrics apart is the depth and breadth of their true business knowledge.”
            -- Director, Contracts, Top 20 Pharma

  • “PharmaMetrics solutions can either be a complete business solution or independent modules that supplement your current business infrastructure.”
            -- Director, Contracts, Top 20 Pharma

  • “The implementation was easy and I didn’t need any training whatsoever. If you know how to do your job – the system follows your process. You don’t have to change your process to meet the systems needs.”
                -- Director, Corporate Compliance, Dermatological Company

  • “The industry experience and knowledge of their expanded team of experts sets them far apart from other service providers within the industry.”
                -- Director of Contracting, Amarin Pharma Inc.

  • “PharmaMetrics offers the services and software to handle all of our Managed Markets needs from front-end pricing analytics to the ban-end contract administration.”
            -- Sr. Director, Contract Management, Top 10 Pharma

  • “The robust reports generated enable more accurate forecasting and financial analysis.”
            -- Sr. Director, Top 10 Pharma